◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › P › PRGO

Perrigo Company PLC (PRGO) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · DATA UPDATED 2026-09-07

Perrigo Company PLC (PRGO) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Dublin, Ireland with about 8,100 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, PRGO reported $4.3B in revenue and ($1.4B) in net income.

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.

Interactive charts & full statements → Open the PRGO valuation workbench →

PRGO Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$4.1B	$4.3B	$4.4B	$4.7B	$4.5B	$4.1B	$4.1B	$3.9B	$4.7B	$4.9B	$5.3B	$4.6B	$4.1B	$4.1B	$3.5B	$3.2B	$2.8B	$2.3B	$2.0B	$1.8B	$1.4B
Gross Profit	$1.4B	$1.5B	$1.5B	$1.7B	$1.5B	$1.4B	$1.5B	$1.4B	$1.8B	$2.0B	$2.1B	$1.7B	$1.4B	$1.4B	$1.3B	$1.1B	$945M	$746M	$596M	$551M	$402M
Gross Margin %	33.3%	35.1%	35.3%	36.1%	32.7%	34.2%	36.6%	37.0%	38.7%	40.0%	38.9%	37.2%	35.6%	35.6%	36.2%	34.5%	34.3%	32.9%	29.7%	30.2%	27.8%
Operating Income (EBIT)	$215M	$343M	$113M	$152M	$79M	$410M	$265M	$175M	$236M	$598M	($2.0B)	$748M	$567M	$401M	$679M	$569M	$490M	$336M	$247M	$197M	$99M
Operating Margin %	5.2%	8.1%	2.6%	3.3%	1.8%	9.9%	6.5%	4.5%	5.0%	12.1%	-37.9%	16.2%	14.0%	9.9%	19.2%	17.9%	17.8%	14.8%	12.3%	10.8%	6.8%
Net Income	($1.7B)	($1.4B)	($172M)	($13M)	($141M)	($69M)	($163M)	$146M	$131M	$120M	($4.0B)	$128M	$205M	$205M	$442M	$402M	$339M	$223M	$144M	$136M	$74M
Net Margin %	-41.9%	-33.5%	-3.9%	-0.3%	-3.2%	-1.7%	-4.0%	3.8%	2.8%	2.4%	-76.0%	2.8%	5.1%	5.1%	12.5%	12.7%	12.3%	9.8%	7.2%	7.4%	5.1%
EBITDA	($1.2B)	($798M)	$433M	$525M	$356M	$696M	$518M	$662M	$906M	$1.1B	($4.2B)	$754M	$1.2B	$760M	$939M	$859M	$713M	$594M	$411M	$325M	$289M
Earnings Per Share (EPS)	$-12.53	$-10.29	$-1.25	$-0.09	$-1.05	$-0.52	$-1.19	$1.07	$0.95	$0.84	$-28.00	$0.91	$1.78	$1.78	$4.68	$4.27	$3.63	$2.40	$1.54	$1.43	$0.79
Shares Outstanding (M)	140M	138M	137M	135M	134M	134M	136M	136M	138M	143M	143M	140M	116M	116M	94M	94M	94M	93M	94M	95M	94M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PRGO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$1.0B	$969M	$1.1B	$1.0B	$1.1B	$1.0B	$1.1B	$1.1B
Gross Profit	$314M	$326M	$362M	$377M	$363M	$392M	$386M	$404M
Gross Margin %	30.7%	33.6%	32.6%	36.1%	34.4%	37.6%	33.9%	37.2%
Operating Income (EBIT)	$24M	$34M	$85M	$73M	$45M	$47M	$114M	$80M
Operating Margin %	2.3%	3.5%	7.6%	7.0%	4.3%	4.5%	10.0%	7.4%
Net Income	$74M	($399M)	($1.4B)	$8M	($8M)	($6M)	($44M)	($21M)
Net Margin %	7.3%	-41.1%	-127.8%	0.7%	-0.8%	-0.6%	-3.9%	-1.9%
EBITDA	$144M	($284M)	($1.2B)	$162M	$129M	$127M	$193M	$162M
Earnings Per Share (EPS)	$0.53	$-2.87	$-10.24	$0.05	$-0.06	$-0.05	$-0.32	$-0.15
Shares Outstanding (M)	140M	139M	138M	139M	138M	138M	138M	138M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PRGO Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$252M	$238M	$363M	$406M	$307M	$156M	$636M	$388M	$593M	$699M	$655M	$1.2B	$694M	$694M	$554M	$513M	$374M	$314M	$258M	$248M	$129M
Capital Expenditures (CapEx)	$77M	$93M	$118M	$102M	$96M	$152M	$170M	$138M	$103M	$89M	$106M	$137M	$172M	$172M	$104M	$120M	$99M	$56M	$59M	$57M	$105M
Free Cash Flow (FCF)	$175M	$145M	$245M	$304M	$211M	$4M	$466M	$250M	$490M	$610M	$549M	$1.1B	$522M	$522M	$450M	$393M	$275M	$258M	$199M	$191M	$24M
FCF Margin %	4.2%	3.4%	5.6%	6.5%	4.7%	0.1%	11.4%	6.5%	10.4%	12.3%	10.4%	23.1%	12.8%	12.8%	12.7%	12.4%	10.0%	11.4%	9.9%	10.5%	1.7%
Dividends Paid	$200M	$159M	$152M	$150M	$142M	$130M	$124M	$112M	$105M	$91M	$83M	$72M	$65M	$46M	$46M	$33M	$29M	$22M	$20M	$18M	$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PRGO Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$138M	($114M)	$175M	$52M	$76M	($64M)	$313M	$42M
Capital Expenditures (CapEx)	$14M	$14M	$27M	$22M	$19M	$26M	$38M	$27M
Free Cash Flow (FCF)	$124M	($127M)	$149M	$30M	$57M	($90M)	$275M	$15M
FCF Margin %	12.1%	-13.1%	13.4%	2.9%	5.4%	-8.6%	24.1%	1.4%
Dividends Paid	$80M	$40M	$40M	$40M	$39M	$41M	$40M	$38M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PRGO Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$7.6B	$8.5B	$9.6B	$10.8B	$11.0B	$10.4B	$11.5B	$11.3B	$11.0B	$11.6B	$13.9B	$19.4B	$13.9B	$13.9B	$5.4B	$4.0B	$3.2B	$3.1B	$2.5B	$2.6B	$1.9B
Cash & Cash Equivalents	$400M	$532M	$559M	$751M	$601M	$1.9B	$632M	$354M	$551M	$679M	$622M	$418M	$800M	$800M	$780M	$602M	$310M	$98M	$316M	$319M	$30M
Total Liabilities	$5.1B	$5.6B	$5.3B	$6.0B	$6.2B	$5.3B	$5.8B	$5.5B	$5.3B	$5.5B	$7.9B	$9.4B	$5.2B	$5.2B	$3.0B	$2.2B	$1.7B	$2.0B	$1.6B	$1.6B	$1.2B
Total Debt (Short + Long-Term)	$3.3B	$3.7B	$3.6B	$4.1B	$4.1B	$3.5B	$3.6B	$3.4B	$3.2B	$3.3B	$5.8B	$5.0B	$5.4B	$3.2B	$2.1B	$1.4B	$915M	$1.3B	$892M	$915M	$678M
Total Shareholders' Equity	$2.5B	$2.9B	$4.3B	$4.8B	$4.8B	$5.2B	$5.7B	$5.8B	$5.7B	$6.2B	$6.0B	$10.0B	$8.7B	$8.7B	$2.3B	$1.9B	$1.5B	$1.1B	$922M	$934M	$754M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRGO viewer.

Other Companies in DRUG MANUFACTURERS - SPECIALTY & GENERIC

TRLV · Trulieve Cannabis Corp. — $2 billion
PBH · Prestige Brand Holdings Inc — $2 billion
BHC · Bausch Health Companies Inc — $2 billion
ALVO · Alvotech — $2 billion
ANIP · ANI Pharmaceuticals Inc — $2 billion
ETON · Eton Pharmaceuticals Inc — $2 billion
XERS · Xeris Pharmaceuticals Inc — $1 billion
PAHC · Phibro Animal Health Corporation — $1 billion

← PRG All “P” companies PRGS →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.